Ad is loading...
GSIFX
Price
$27.21
Change
-$0.29 (-1.05%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

GSIFX vs VTSNX

Header iconGSIFX vs VTSNX Comparison
Open Charts GSIFX vs VTSNXBanner chart's image
Goldman Sachs International Eq ESG A
Price$27.21
Change-$0.29 (-1.05%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
GSIFX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSIFX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSIFX is a Sell and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. GSIFX (1.03B). VTSNX pays higher dividends than GSIFX: VTSNX (3.29) vs GSIFX (1.32). GSIFX was incepted earlier than VTSNX: GSIFX (32 years) vs VTSNX (14 years). GSIFX is a more actively managed with annual turnover of: 23.00 vs. VTSNX (4.00). GSIFX has a lower initial minimum investment than VTSNX: GSIFX (1000) vs VTSNX (5000000). VTSNX annual gain was more profitable for investors over the last year : 10.92 vs. GSIFX (9.40). GSIFX return over 5 years is better than : 36.56 vs. VTSNX (15.91).
GSIFXVTSNXGSIFX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years14 years-
Gain YTD2.1784.53548%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.03B442B0%
Annual Yield % from dividends1.323.2940%
Returns for 1 year9.4010.9286%
Returns for 3 years-8.07-5.86138%
Returns for 5 years36.5615.91230%
Returns for 10 years69.2329.81232%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals